Performance Verification and Establishment of Reference Intervals for Dendritic Cells, γδT Cells, and Follicular
Archives of Pathology & Laboratory Medicine
|March 13, 2026
Summary
Standardized flow cytometry methods were developed for dendritic cells (DCs), gamma-delta T (γδT) cells, and T follicular helper (Tfh) cells. This study established performance verification and reference intervals for improved clinical application of these immune cell subsets.
Area of Science:
- Immunology
- Clinical Chemistry
- Cell Biology
Background:
- Dendritic cells (DCs), gamma-delta T (γδT) cells, and T follicular helper (Tfh) cells are crucial for immune responses.
- Flow cytometry (FCM) offers precise quantification but lacks standardization for clinical use.
- Standardized performance verification and reference intervals are needed for these immune cell subsets.
Purpose of the Study:
- To standardize peripheral DCs, γδT cells, and Tfh cells analysis using FCM.
- To establish performance verification and reference intervals for these immune cell subsets.
- To facilitate broader clinical application of FCM-based immune cell subset analysis.
Main Methods:
- Collected peripheral whole blood from healthy individuals.
- Measured frequencies of DCs, γδT cells, and Tfh cells and their subpopulations via FCM.
- Evaluated sample stability, reportable range, precision, and linearity based on best practices.
- Established reference intervals for the analyzed immune cell subsets.
Main Results:
- Determined sample stability: DCs (24h at 4°C), γδT cells (96h at 4°C/RT), Tfh cells (instability after 24h at 4°C/RT).
- Established reportable ranges: DCs (5000 cells), γδT cells (250 cells), Tfh cells (1000 cells).
- Confirmed intra-assay/interassay precision and linearity met acceptance criteria; established reference intervals.
Conclusions:
- Systematic performance verification and reference intervals were established for DCs, γδT cells, and Tfh cells via FCM.
- This standardization promotes reliable clinical application of these immune cell subset assays.
- The findings support improved diagnostic and monitoring capabilities for immune-related conditions.


